Genetic epilepsy and neurodegenerative diseases are two common neurological disorders that are conventionally viewed as being unrelated. A subset of patients with severe genetic epilepsies who have impaired development and often go on to die of their disease respond poorly to anticonvulsant drug therapy, suggesting a need for new therapeutic targets. Previously, we reported that multiple GABA A receptor epilepsy mutations result in protein misfolding and abnormal receptor trafficking. We have now developed a model of a severe human genetic epileptic encephalopathy, the Gabrg2 +/Q390X knock-in mouse. We found that, in addition to impairing inhibitory neurotransmission, mutant GABA A receptor g2(Q390X) subunits accumulated and aggregated intracellularly, activated caspase 3 and caused widespread, age-dependent neurodegeneration. These findings suggest that the fundamental protein metabolism and cellular consequences of the epilepsy-associated mutant g2(Q390X) ion channel subunit are not fundamentally different from those associated with neurodegeneration. Our results have far-reaching relevance for the identification of conserved pathological cascades and mechanism-based therapies that are shared between genetic epilepsies and neurodegenerative diseases. npg
a r t I C l e S Genetic epilepsies (GEs) are common neurological disorders that are frequently associated with ion channel gene mutations 1 . Although many GEs are relatively benign, there is a group of GEs, the epileptic encephalopathies, which include Dravet syndrome, that are associated with intractable seizures, impaired development, severe cognitive impairment and sudden death. It is not known, however, whether the intractable seizures or some underlying progressive pathological processes are responsible for their clinical outcomes or whether the clinical features of the epileptic encephalopathies are caused by the impaired channel function, the presence of intracellular mutant ion channel protein or both.
The epileptic encephalopathy Dravet syndrome has been shown to be associated with mutations in sodium channel (SCN1A, SCN2A and SCN1B) [2] [3] [4] [5] and GABA A receptor (GABRG2 (refs. 6,7) and GABRA1 (ref. 8)) channel subunit genes. GABRG2(Q390X) is a mutation heterozygously associated with Dravet syndrome 7 (note that the GABRG2(Q390X) mutation is also referred to as GABRG2(Q351X) 7, 9, 10 when it does not include the 39 amino acid signal peptide). We have extensively characterized the cellular effects of this mutation in vitro [9] [10] [11] , demonstrating that, similar to many other truncated proteins, γ2(Q390X) subunits are nonfunctional. In addition, however, the subunits accumulated in the endoplasmic reticulum (ER), where they produced dominant-negative suppression of the biogenesis and trafficking of wild-type subunits 10 . The γ2(Q390X) subunits dimerized quickly once translated 9 , accumulated and disturbed cellular hemostasis in a concentration-dependent manner 11 . It is well established that sustained ER stress leads to neurodegeneration 12 . However, the long-term cellular consequences of a misfolded mutant ion channel subunit associated with GE have not been addressed.
We generated a heterozygous Gabrg2 +/Q390X knock-in (KI) mouse and compared it with a heterozygous Gabrg2 +/− knockout (KO) mouse that has loss of functional γ2 subunits without accumulation of the mutant subunits. The Gabrg2 +/− mouse has been reported to have mild hyperanxiety 13 and to have brief absence seizures only in mice with the seizure prone DBA2J genetic background 14 . In contrast, we found that Gabrg2 +/Q390X mice had a severe epilepsy phenotype that included spontaneous generalized tonic-clonic seizures in mice with the seizure-resistant C57BL/6J background, suggesting that the mutation produces epilepsy by a mechanism(s) other than simple haploinsufficiency. Furthermore, we found that Gabrg2 +/Q390X mice had increased mortality, reminiscent of sudden unexpected death in epilepsy (SUDEP) in humans. We compared the KI and KO mice functionally and biochemically and found that Gabrg2 +/Q390X mice formed intraneuronal detergent-resistant, high molecular-mass protein complexes containing γ2 subunits and displayed widespread caspase 3 activation and sporadic neuronal death in the mouse brain, especially in the cortex, that increased in severity with aging. Our results provide evidence that an epilepsy ion channel gene mutation directly causes chronic neurodegeneration in vivo, and the presence of neurodegeneration, in addition to intractable seizures, provides a possible explanation, at least in part, for several key features of epileptic encephalopathies, including the bases for phenotypic severity, drug resistance, progressive course and poor outcome. Our findings suggest that the protein metabolism of an ion channel epilepsy mutation is not fundamentally different from that associated with neurodegeneration, and drugs developed to treat neurodegeneration might therefore be repurposed to treat severe genetic epilepsies by targeting the same mechanisms. a r t I C l e S RESULTS Mutant g2(Q390X) subunits are aggregation prone GABA A receptors are the major mediators of inhibitory neurotransmission in the brain and are primarily composed of 2α, 2β and 1γ subunits (Supplementary Fig. 1a ). The GABRG2(Q390X) mutation was identified in two separate pedigrees with epilepsy, including Dravet syndrome 7 , and produced a truncated subunit with the loss of 78 C-terminal amino acids (Supplementary Fig. 1b ). We used protein structure modeling of the wild-type and mutant γ2 subunits without the extracellular N-terminal domain to predict the potential consequences on structure of the mutant subunit. For the mutant γ2(Q390X) subunit, the hydrophobic fourth transmembrane α-helix (YARIFFPTAFCLFNLVYWVSYLYL) was deleted and a new α-helix with many charged amino acids (KDKDKKKKNPAPTIDIRPRSATI) was found to assume its location (Fig. 1a) . The upper domain of the wild-type γ2 subunit was mainly hydrophobic and embedded in the membrane as a transmembrane domain, whereas the lower domain was hydrophilic and intracellular ( Fig. 1a) . The mutant γ2(Q390X) subunit had more hydrophilic surface area than the wild-type subunit (Fig. 1a) as a result of the new α-helix (KDKDKKKKNPAPTIDIRPR SATI) that was found to be unstable in the membrane, thereby changing the subunit from a transmembrane protein to a globular cytosolic protein. The remaining hydrophobic surfaces in the α-helices of the mutant subunit were no longer in the membrane and were predicted to become 'sticky' in solvent, that is, the domains were predicted to bind to each other or to other proteins as a result of hydrophobic interactions. On the basis of a docking study for multiple interacting molecules, we determined that a number of relatively stable homodimer conformations might be formed as a result of nonspecific self-interactions of mutant γ2 subunits ( Supplementary Fig. 1c The GABRG2(Q390X) mutation associated with the epileptic encephalopathy Dravet syndrome caused the mutant subunit to be aggregate prone and to accumulate intracellularly. (a) Predicted structural models. Left and middle, protein surfaces of wild-type γ2 and mutant γ2(Q390X) subunits, respectively, where green indicates hydrophobic residues and red shows hydrophilic (polar or charged) residues. Right, the mutant and wild-type subunits superimposed with the same orientation as the left and middle panels (γ2 subunit in cyan/blue and γ2(Q390X) subunit in yellow/orange). The transmembrane 4 (TM4) α-helix (YARIFFPTAFCLFNLVYWVSYLYL) in the wild-type γ2 subunit and a new α-helix (KDKDKKKKNPAPTIDIRPRSATI) in the mutant γ2(Q390X) subunit are shown in highlight with edged representations. (b) The Gabrg2 +/Q390X KI mouse was constructed with insertion of a DraI restriction site in the mutant allele. (c) Wild-type γ2 subunits or mutant γ2(Q390X) subunit monomers and oligomers were detected in lysates from HEK 293T cells coexpressing α1β2γ2 or α1β2γ2(Q390X) subunits (HEK), lysates from wild-type and KI mouse thalami (1 week), wild-type and Gabrg2 +/Q390X mouse cortical membrane preparations (2 months), and immunopurified γ2 subunits from wild-type and KI mouse cortex (ctx) and cerebellum (cb) (~1 year). (d) γ2(Q390X), but not γ2, subunits accumulated intracellularly in live α1β2γ2 YFP (WT) or α1β2γ2(Q390X) YFP (Mut) subunit-transfected HEK 293T cells (HEK) and COS-7 (COS) cells and γ2 YFP or γ2 YFP and γ2(Q390X) YFP subunit-transfected cultured rat cortical neurons. (e) Image showing a coronal brain section of somatosensory cortex layers II-VI from a 16-month-old wild-type mouse stained with antibodies to γ2 subunit (green) and NeuN (red) and with To-pro-3 (blue). White line designates the approximate layers surveyed in g and h. (f,g) Freshly prepared brain sections from 2-4-month-old (f) or over 16-month-old (g) wild-type and KI littermates were immunostained with antibody to γ2 subunit and visualized with Alexa-488 fluorophores (green) under confocal microscopy. The nuclei were stained with To-pro-3 (blue). (h) Fluorescence intensities of γ2 subunits conjugated with Alexa-488 fluorophores in cortical brain sections from wild-type and heterozygous mice were quantified (unpaired t test; P = 0.008, WT versus het for 2-4 months old; P < 0.0001, WT versus het for 16 months and 2-4 months versus 16 months (n = 5 for 5 pairs of mice; five independent experiments, error bars represent s.e.m.). **P < 0.01, ***P < 0.001 versus wild type, ### P < 0.001 versus 2-4 months old mice. In c, the red arrows designate the mutant γ2 subunit monomers, the green arrows designate the wild-type γ2 subunits and the blue arrows designate the mutant γ2 subunit aggregates. In f and g, the red arrows designate the somatic regions of individual cells. npg a r t I C l e S and a number of nonspecific hetero-dimer conformations might be formed between the mutant γ2 subunit and its wild type-partnering α1 subunit ( Supplementary Fig. 1d ). All of these subunit dimers were predicted to be stable.
The GABRG2(Q390X) mutation promoted intraneuronal accumulation of mutant g2(Q390X) subunits in KI mice To fully characterize the pathological basis for the epilepsy associated with the Q390X mutation, we generated the heterozygous Gabrg2 +/Q390X KI mouse line with a standard gene targeting strategy ( Fig. 1b) . In both transfected HEK 293T cells and in brains from 1-week-old to 14-month-old Gabrg2 +/Q390X mice, mutant γ2(Q390X) subunits formed oligomers, likely dimers, tetramers and/or high molecular mass protein complexes on SDS-PAGE ( Fig. 1c) . The predicted molecular mass of the mutant γ2(Q390X) subunit was 40 kDa, and the full-length wild-type γ2 subunit was about 50 kDa 10 (Fig. 1c) . In HEK 293T and COS-7 cells cotransfected with α1, β2 and γ2(Q390X) YFP subunits and in cultured rat cortical neurons transfected with γ2 YFP or γ2 YFP and γ2(Q390X) YFP subunits alone, the mutant subunits accumulated intracellularly in the ER (Fig. 1d ).
Immunohistochemical staining with antibody to γ2 subunit consistently indicated that γ2 subunits accumulated in the cortex of 2-and 16-month-old KI mice ( Fig. 1e-g) , as well as in postnatal day 0 (P0) KI mice and in multiple brain regions, including the cortex ( Supplementary Fig. 2 ). The mutant γ2 subunit fluorescence intensity was increased in cultured neurons (22.20 ± 0.97 versus 37.20 ± 2.5, n = 5 cultures, P = 0.0005, unpaired t test), as well as in both 2-4-and 16-month-old Gabrg2 +/Q390X mice (Fig. 1h) . In the brains of P0 mice, the γ2 subunit staining was also stronger in Gabrg2 +/Q390X than in wild-type mice, and in cerebellum, γ2 subunit staining was prominent in the Purkinje cells layer, which contains Purkinje cells and Bergmann glia cells ( Supplementary Fig. 2 ). The increased γ2 subunits in the somatic regions in Gabrg2 +/Q390X mice across different ages suggest that there was consistent ER retention of the mutant subunit protein.
Gabrg2 +/Q390X KI mice had reduced viability SUDEP is a substantial concern for patients with epilepsy, especially those with frequent and severe seizures, such as those associated with Dravet syndrome 15 . SUDEP has been characterized in the Scn1a +/− KO mouse model of Dravet syndrome 16 , but the basis for SUDEP remains unclear. SUDEP could be a result of brain-driven cardiac dysfunction during seizures or to other non-cardiac mechanisms 15, 17 . Because the GABRG2(Q390X) mutation is associated with Dravet syndrome, we determined the mortality rate of heterozygous KI mice ( Fig. 2) . We genotyped all mice by PCR of tail DNA ( Fig. 2a ) and included all of the retrieved dead pups. We found that heterozygous and homozygous KI mice were born with a reduced Mendelian ratio ( Fig. 2b) . Homozygous Gabrg2 Q390X/Q390X mice, however, did not survive beyond the day of birth ( Fig. 2e) , consistent with a previous report for homozygous Gabrg2 −/− KO mice 18 . However, gross morphology of heterozygous and homozygous KI mice (Fig. 2c) , and the cellular structure of heterozygous KI pup's brains ( Fig. 2d ), appeared to be normal. Although viable, heterozygous KI mice had increased mortality throughout life (measured up to 30 weeks) and wild-type mice had minimal to no death over that time period ( Fig. 2e) . The increased death rate for heterozygous KI mice was likely related to severe generalized seizures, consistent with our observation that 
Gabrg2 +/Q390X KI mice had spontaneous seizures and neurobehavioral comorbidities
We observed spontaneous generalized tonic-clonic-seizures in Gabrg2 +/Q390X mice at 19 d of age (Supplementary Video 1) . To characterize the seizure phenotype of heterozygous KI mice, we recorded synchronized video electroencephalograms (EEGs) in mice. The EEGs demonstrated occurrence of spontaneous electrographic and behavioral seizures as well as interictal discharges ( Fig. 3a and Supplementary Fig. 3 ). With blockade of GABA A receptors by pentylenetetrazol (PTZ, 50 mg per kg of body weight), heterozygous KI mice had lowered seizure threshold than wild-type littermates, as demonstrated by early onset and increased percentage of clonic seizures and tonic hind limb extension (Fig. 3b,c) . We chose the lower dose of PTZ because of the high mortality rate of Gabrg2 +/Q390X mice at higher doses of PTZ (70 mg per kg or 85 mg per kg). We then assessed potential behavioral comorbidities of epilepsy in Gabrg2 +/Q390X mice. We performed the elevated zero maze (EZM) test and the open field (OF) test. In the EZM test, heterozygous KI mice spent substantially less time in the open arm (121.6 ± 6.46 s versus 94.5 ± 3.67 s, n = 59 for wild type and 57 for heterozygous KI, unpaired t test) and had reduced total entries into the open arm (16.24 ± 0.91 versus 13.39 ± 0.61, n = 59 for wild type and 57 for heterozygous KI, unpaired t test) than wild types. In the OF test, heterozygous KI mice had increased total distance traveled in the first 10 min (1,245.4 ± 31.2 cm versus 1,497.4 ± 54.1 cm, n = 35 for wild type and 47 for heterozygous KI, unpaired t test), but tended to be quiet and stayed in the corner of the chamber in the later time segments and had reduced time spent in the center during the 1-h test (31.28 ± 1.113 min versus 19.77 ± 1.010 min, n = 35 for wild type and 47 for heterozygous, P < 0.0001, unpaired t test). This was consistent with the fact that the heterozygous KI mice spent less time in the center resting (42.98 ± 2.58 s versus 33.72 ± 2.42 s, n = 35 for wild type and 47 for heterozygous KI mice, P = 0.012, unpaired t test) and more time in the periphery resting (81.06 ± 6.33 s versus 106.4 ± 5.82 s, n = 35 for wild type and 47 for heterozygous KI mice, P = 0.045, unpaired t test) per 5-min segment. Gabrg2 +/Q390X KI mice had multiple phenotypes, including spontaneous seizures, SUDEP, enhanced anxiety and deficits in social behaviors, whereas Gabrg2 +/− KO mice have been reported to be seizure free 13 or to have absence epilepsy only in a specific seizureprone genetic background 14 .
GABAergic mIPSC amplitude and frequency were reduced more in Gabrg2 +/Q390X KI mice than in Gabrg2 +/− KO mice Gabrg2 +/Q390X KI mice had severe epilepsy, increased mortality and neuropsychiatric comorbidities. By contrast, Gabrg2 +/− KO mice were Figure 5 Gabrg2 +/Q390X KI mice were not equivalent to Gabrg2 +/− KO mice with respect to the remaining wild-type GABA A receptor subunit expression. (a-d) Lysates from different brain regions (cortex (ctx), cerebellum (cb), hippocampus (hip) and thalamus (thal)) from heterozygous (het) KO and KI mice were subjected to SDS-PAGE and immunoblotted with antibody to γ2 subunit (a,b) or α1 subunit (c,d).
(e-h) Integrated density values (IDVs) for total γ2 and α1 subunits from wild-type and het KI (e,g) or wild-type and het KO (f,h) mice were normalized to the Na + /K + ATPase or anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) loading control (LC) in each specific brain region and plotted. *P < 0.05, **P < 0.01, ***P < 0.001 versus wild type. n = 5 pairs of mice for KI and 5 pairs of mice for KO. Error bars represent s.e.m. Full-length gels are presented in Supplementary Figure 4 . npg a r t I C l e S reported to be seizure free 13 or to have absence epilepsy, but not thermal seizures, in a specific seizure-prone genetic background such as DBA2J 14 . We next sought to determine whether there was a difference in GABAergic synaptic strength between these animals. It is generally believed that a loss of function mutation such as a truncation mutation causes disease because of haploinsufficiency of the affected gene, and KO models have therefore been widely used for studying human diseases 19 . We previously demonstrated in vitro that, in addition to being nonfunctional, mutant γ2(Q390X) subunits suppress the biogenesis and function of wild-type-partnering subunits 9 . To determine the effect of mutant γ2(Q390X) subunits on GABAergic neurotransmission in KI mice, we recorded GABAergic miniature inhibitory postsynaptic currents (mIPSCs) in cortical layer VI neurons in age-matched Gabrg2 +/Q390X KI and Gabrg2 +/− KO mice 20 (Fig. 4) . The choice of cortical layer VI neurons was based on the involvement of thalamocortical circuitry in seizure generation and neurons in both this layer and layer IV receive direct projection of ventrobasal complex neurons 21 . Compared with wild-type mice, heterozygous KI mice had reduced mIPSC amplitudes and frequency (2.94 ± 0.34 versus 1.69 ± 0.40, n = 16 cells from 11 slices from 7 mice for wild type, n = 13 cells from 8 slices rom 6 mice for het, unpaired t test, P = 0.021) (Fig. 4a,c) , whereas there was no significant difference between wild-type and heterozygous KO mice in either amplitude or frequency (3.61 ± 0.91 versus 2.58 ± 0.29, n = 8 cells from 6 slices from 5 mice for wild type, n = 9 cells from 7 slices from 6 mice for het, unpaired t test, P = 0.28) (Fig. 4b,d ).
Gabrg2 +/Q390X and Gabrg2 +/− mice had different biogenesis to the remaining wild type-partnering subunits The reduced mIPSC amplitude and frequency in Gabrg2 +/Q390X mice were likely a result, in part, of the reduction of wild-type γ2 subunits, as well as of a loss of α1 subunits as a consequence of reduced α1βγ2 receptors being assembled and trafficked to synapses. This is not surprising given the critical role of γ2 subunits in synaptic GABA A receptor maintenance and clustering 22 . Consistent with the electrophysiological recordings, biochemical studies demonstrated that total levels of both wild-type γ2 and α1 subunits were reduced in multiple brain regions, including cortex, in the KI mice ( Fig. 5 and Supplementary Fig. 4) , whereas total levels of γ2 subunits were reduced to a lesser extent and total levels of α1 subunits were unaltered in the age-matched heterozygous KO mice (Fig. 5a,c, Fig. 4) . These results suggest that neuronal inhibition was more impaired in the KI than in the KO mice. The data also suggest that the mutant γ2(Q390X) subunits suppress the biogenesis of their wild-type-partnering subunits and wild-type γ2 subunits.
Younger Gabrg2 +/Q390X KI mice had intraneuronal accumulation of g2 subunits Our in vitro results suggest that mutant γ2(Q390X) subunits fail to traffic to the cell surface 10 and accumulate inside neurons. In Gabrg2 +/Q390X mice, we found that the staining of γ2 subunits was more intense in neuronal somata compared with the age-and gender-matched wild-type littermates at 6 months of age ( Fig. 6a-c) . However, the fluorescence signal intensity in the whole-field or non-somatic regions was reduced in the Gabrg2 +/Q390X mice (Fig. 6a-c) . The γ2 subunit puncta were colocalized with the inhibitory postsynaptic marker gephyrin. We further compared the distribution of the γ2 subunits in wild-type and heterozygous KI mice in synaptosomes and at the cell surface by subcellular fractionation or live brain slice surface biotinylation. γ2 subunit expression was reduced in heterozygous KI mice in the synaptosomes ( Fig. 6d and Supplementary Fig. 4 ) and at the cell Figure 6 Younger Gabrg2 +/Q390X KI mice had increased γ2 subunit accumulation in neuronal somata, but reduced expression of γ2 subunits in synaptosomes and on the cell surface.
(a) The brains from 6-month-old wild-type and heterozygous (het) KI littermates were blocked, short fixed with 4% paraformaldehyde for 30 min and immersed in 30% sucrose overnight. The brain tissues were sectioned by cryostat at 15 µm and stained with rabbit antibody to γ2 subunit (green), mouse antibody to gephyrin (red) and the cellular nucleus marker To-pro-3 (blue). The presented images are from cortex layers V-VI. (b) An enlarged image from the wild-type overlay was used to illustrate the quantification of the fluorescent intensity values in somatic and non-somatic regions with ImageJ. The fluorescent intensities of the whole field, somatic or non-somatic regions were measured. (c) The fluorescence intensity values in the nuclei were used as background values that were subtracted in each condition. The total fluorescence intensity values from the whole field and non-somatic regions were reduced, but were increased in the somata in the het mouse brains (P = 0.0048 for whole field, P = 0.0031 for somata, P = 0.0136 for nonsomata, n = 11 wild-type mice and 12 het mice, unpaired t test).
(d,f) The forebrains of 2-4-month-old mice were subfractionated. Equal amounts of protein from nuclei and cell debris (p1), total cytosol (s1), cytosol and light membrane (s2), and synaptosomes (spm) were analyzed by SDS-PAGE and immunoblotted with antibody to γ2 subunit. The protein IDVs in each fraction were normalized to their own loading control (LC) Na + /K + ATPase or β-Tubulin (P = 0.034 wild type versus het spm, n = 4 pairs of mice, 4 independent experiments, unpaired t test). (e,g) The surface proteins from the live mouse brain slices were biotinylated and analyzed by SDS-PAGE and immunoblotted with antibody to γ2 subunit (P = 0.011 for cor, P = 0.0088 for cb, P = 0.0154 for hip, P = 0.0007 for thal, n = 4 pairs of mice; one-sample t test). *P < 0.05, **P < 0.01, ***P < 0.001 versus wild type. Error bars represent s.e.m. Full-length gels for d and e are presented in Supplementary Figure 4 . npg a r t I C l e S surface ( Fig. 6e-g and Supplementary Fig. 4) . In summary, our data suggest that γ2 subunits in synapses were reduced in spite of their accumulation in the neuronal somatic region.
Older mutant Gabrg2 +/Q390X KI mice had increased caspase 3 activation and cell death in the cerebral cortex Although no in vivo evidence for neurodegeneration in genetic epilepsy has been reported previously, it has been established in multiple neurodegenerative diseases that sustained accumulation and aggregation of mutant protein will eventually lead to neurodegeneration [23] [24] [25] [26] . Thus, given that the mutant γ2(Q390X) subunit is aggregation prone and relatively stable 9 , its sustained expression could lead to neurodegeneration. To examine neuronal apoptosis in heterozygous KI mice, we stained for γ2 subunits and cleaved caspase 3 in 1-yearold mice (Fig. 7) . Cleaved caspase 3 has been used as a marker for cellular apoptosis because of its role in executing cell death 27 . In Gabrg2 +/Q390X KI mice, but not wild-type mice, increased cleaved caspase 3 staining and γ2 subunit accumulation were both present in the deep layers of the cortex (Fig. 7a,b) . The intensity of both γ2 subunit and cleaved caspase 3 staining was higher in the neuronal somata of mutant than in wild-type mice (Fig. 7f) . Cleaved caspase 3 was mainly present in the neuronal cytoplasm ( Fig. 7c) and colocalized with γ2 subunits in what appeared to be aggregates (Fig. 7d) . These cleaved caspase 3-γ2 subunit aggregates were absent in the old wild-type and young (2 month) KI mice. They were detectable in the 5-6-month-old KI mice, but were prominent in old (1 year or older) KI mice with neuronal loss in the cortex (Supplementary Figs. 5-8) .
We used paraffin-embedded brain tissues because the staining was focused on neuronal somatic regions. Synaptic proteins were poorly preserved in these tissues compared with those with short fixation (Figs. 1f,g and 6a,b and Supplementary Fig. 9 ).
We also asked whether the mutant γ2 subunit aggregates were associated with neuronal death. To do this, we performed TUNEL staining and found that the percentage of TUNEL-positive neurons in cortical layer IV-VI neurons was higher in 1-year-old heterozygous KI mice than in age-matched wild-type mice (Fig. 7e,g) . It is believed that age is a risk factor for neurodegeneration and protein aggregation, and this concept has been well studied in neurodegenerative diseases that are caused by both genetic and environmental factors [28] [29] [30] [31] . Our data are consistent with studies of neurodegeneration; the older heterozygous mice had cleaved caspase 3 activation, cytoplasmic caspase 3-γ2 subunit-positive aggregates and neuronal death, whereas these features were not prominent in the younger Gabrg2 +/Q390X mice (Supplementary Figs. 5-8 and 10-12) .
The activation of caspase 3 could be a result of the accumulation of mutant g2(Q390X) subunits independent of seizure activity Although caspase 3 activation is a crucial event for neuronal death and an established feature of many neurodegenerative diseases 32 , caspase 3 activation can be caused by other neuronal activities 33 . We therefore examined the level of caspase 3 activation in cultured neurons in which no seizure activity was present. We found that more neurons were caspase 3 positive in those cultured from the heterozygous Gabrg2 +/Q390X KO mice than from the wild-type mice (4.6 ± 1.7% versus 29.4 ± 6.7%, n = 4 cultures, P = 0.015, unpaired t test; Fig. 8a) . In HEK 293T cells, we expressed wild-type γ2 or mutant γ2(Q390X) subunits with progressively increasing levels of cDNA and found that the cells expressing mutant γ2(Q390X) subunits npg a r t I C l e S had increased ER stress, as evidenced by the upregulated expression of ER stress hallmark GADD153 (Fig. 8b,c) . Notably, the wild-type γ2 subunits also increased ER stress with high amounts of transfected cDNA. This suggests that wild-type γ2 subunits also cause ER stress when assembly partners are lost and when they are present at high intracellular levels. The sustained ER stress could lead to cell death, as evidenced by increased caspase 3 activation in the cells expressing the mutant γ2(Q390X) subunit. The expression level of caspase 3 in cells expressing mutant γ2(Q390X) subunits was similar to that in control cells treated with the apoptosis-inducer staurosporine (3 µM) for 4 h (Fig. 8d) ; in contrast, caspase 3 activation was not or only minimally present in cells expressing wild-type γ2 subunits ( Fig. 8e and Supplementary Fig. 4 ).
DISCUSSION
Dravet syndrome is an epileptic encephalopathy in which "the epileptic activity itself may contribute to severe cognitive and behavioral impairments above and beyond what might be expected from the underlying pathology alone (for example, cortical malformation), and that these can worsen over time" 34 . Our results suggest that, in addition to the disinhibition produced by substantial loss of functional γ2 subunits leading to epilepsy, the progressive behavioral changes and worsening epilepsy caused by the GABRG2(Q390X) mutation may also be a result of neuronal dysfunction and neurodegeneration caused by the accumulation and aggregation of a truncated ion channel protein that increases cell stress and leads to chronic neurodegeneration. There are no reports that the mutant protein associated with Dravet syndrome causes neurodegeneration. However, although not definitive, there are several lines of evidence that neurodegeneration may occur in a subset of patients with GE. For example, a recent study of a brain specimen from a Dravet syndrome patient harboring the GABRG2(Q40X) mutation indicated that the mutant γ2 subunits formed protein aggregates, but the details of the aggregates are not available 6 . Our in vitro study revealed that mutant γ2(Q390X) subunits produced substantial protein aggregates, whereas mutant γ2(Q40X) subunits were undetectable (Supplementary Fig. 13) . In addition, a study using brain magnetic resonance imaging (MRI) in a large group of GE patients 35 found substantial cortical atrophy, suggesting possible neuronal loss. A brain morphometry study in Dravet syndrome patients revealed global volume reductions of gray and white matter, as well as a correlation between the intracranial volume reduction and increased age 36 . The lack of clear clinical evidence of an association of mutations in GE and neurodegeneration may be a result of epileptic encephalopathies that occur in only a small subset of epilepsy patients, and the relationship may have gone unrecognized. In addition, the major cause of Dravet syndrome is SCN1A mutations, which may have a different pathophysiology than GABRG2 mutations.
In Dravet syndrome, altered neurotransmission and seizure phenotypes have been extensively characterized in an Scna1 +/− KO mouse as well as in a nonsense mutation Scn1a KI mouse 37, 38 . However, no mutant protein was detected in Scn1a KI mice, suggesting haploinsufficiency. We found that truncated γ2(Q390X) subunits were produced, that they accumulated in neurons and that, in older Gabrg2 +/Q390X KI mice, they formed sporadic protein aggregates in multiple brain regions. These findings are consistent with the widespread expression of γ2 subunits in the brain 39 . We previously reported that mutant γ2(Q390X) subunits produced dominant-negative suppression of wild-type-partnering and wild-type γ2 subunits 10 , and had slow degradation and disturbed cellular homeostasis 26 . Our findings suggest that an ion channel mutation associated with a severe GE results in activated caspase 3, protein aggregates and chronic neurodegeneration.
Gabrg2 +/Q390X KI mice phenocopy the major symptoms of the human epileptic encephalopathy Dravet syndrome and the phenotypes of patients that heterozygously carry the mutation (Online Methods). Gabrg2 +/Q390X KI mice had multiple forms of epilepsy, including generalized tonic-clonic seizures and neuropsychiatric comorbidities, such as increased anxiety and social deficits and SUDEP. However, we did not find a difference in motor coordination between control and mutant mice up to 6 months of age, as determined by the rotarod test. This is in contrast with the findings that there are severe ataxia in Figure 8 Increased ER stress and caspase 3 activation were detected in cells expressing mutant γ2(Q390X) subunits. (a) Hippocampal neurons from P0 wild-type and heterozygous (het) KI mice were grown in cell culture for 3 weeks, and neurons were stained with rabbit polyclonal antibody to cleaved caspase 3 (green) and mouse monoclonal antibody to γ2 subunit (red). (b,c) Lysates from HEK 293T cells expressing γ2 or γ2(Q390X) subunits with progressively increased cDNA concentrations were immunoblotted with either antibody to γ2 subunit or to the ER stress hallmark GADD153 with an Na + /K + ATPase loading control (LC) (b), and the normalized GADD153 IDVs were plotted (ns, not significant; *P < 0.05, **P < 0.01, ***P < 0.001 versus wild type of the same cDNA amount, n = 4 different transfections) (c). (d,e) HEK 293T cells were either untransfected (con) or transfected with γ2 (WT) or γ2(Q390X) (mut) subunits. The apoptosis inducer staurosporine (3 µM) was applied for 4 h as positive control (con + STS). The cells were harvested 2 d after transfection and analyzed by SDS-PAGE and immunoblotted by the antibody to cleaved caspase 3 (d). The IDVs for each condition were normalized to the loading control Na + /K + ATPase or β-tubulin and plotted (***P < 0.001 versus wild type, n = 4 different transfections) (e). Error bars represent s.e.m. Full-length gel for e is presented in Supplementary Figure 4 .
a r t I C l e S heterozygous Scna1 +/− KO mice at P21 (ref. 40) . This suggests that there may be differences in the comorbidities between the severe epilepsies associated with an SCN1A mutation and a GABRG2 mutation. Comparison of Gabrg2 +/Q390X KI and Gabrg2 +/− KO mice revealed that GABAergic synaptic transmission in KI mice was not equivalent to GABAergic synaptic transmission in KO mice caused by the simple loss of one Gabrg2 allele. The difference in GABAergic neurotransmission between the KI and KO mice was likely a result of differences in wild-type GABA A receptor subunit biogenesis. Gabrg2 +/− KO mice only had a small reduction in γ2 subunit expression, whereas α1 subunit expression was unchanged. In contrast, total expression of both α1 subunits and the remaining wild-type γ2 subunits in Gabrg2 +/Q390X mice was reduced in all of the major brain regions, including cerebral cortex, cerebellum, hippocampus and thalamus, compared with wild-type littermates and Gabrg2 +/− KO mice. This dominantnegative suppression of the wild-type subunits by γ2(Q390X) subunits is likely a result of oligomerization of mutant γ2(Q390X) subunits with wild-type subunits, thereby trapping the wild-type subunits in the ER. This likely explains, in part, why Gabrg2 +/Q390X KI mice had a more severe epilepsy phenotype.
Our results challenge the widely held belief that neurodegeneration does not occur in GEs. Much effort has been directed towards identifying neuronal death in different animal models of epilepsy, such as pilocarpine, kainic acid kindling and thermal animal models 41 . However, these are models of acquired, rather than genetic, epilepsies. The cellular environment in Gabrg2 +/Q390X mice is different from that in the external stimulus-induced seizure models because the mutation is present from conception. We found that the KI mice had intraneuronal γ2 subunit-caspase 3 protein aggregates and had caspase 3 activation and chronic neurodegeneration, although these features were not present in younger mice expressing the mutant subunit. The reduction of neuronal number was 15% in the somatosensory cortex in the old KI mice, as indicated by neuronal marker NeuN expression. However, sporadic neuronal death was observed in multiple brain regions, including cortex, hippocampus, thalamus and cerebellum. In a given neuron, its viability and caspase 3 activation were likely correlated with the abundance of γ2(Q390X) subunits. We previously demonstrated that ER-retained trafficking-deficient γ2 subunits produce ER stress 11 . It is possible that the activated caspase 3 also alters synaptic activity, as caspase 3 is required for the refinement of neuronal circuits during development that involves selective elimination of axons, dendrites and synaptic connections 32, 33 . However, it should be noted that, although mutant γ2 subunits accumulated in the neurons of mice at all ages, neuronal death in the KI mice was highly variable, chronic and subject to substantial developmental effect, as we found that neuronal death was only evident in the older KI mice. The identification of mutant protein aggregation in Gabrg2 +/Q390X KI mice has far reaching implications for both disease classifications and therapeutic strategies. Although GE and neurodegenerative diseases are two conventionally unrelated disease entities, our results suggest that the mutant protein metabolism and the engaged signaling pathways, such as caspase 3 activation, may be similar in both disorders. Thus, the therapeutic developments in neurodegeneration and other diseases with similar mechanisms could be repurposed to treat epilepsy by targeting the same signaling pathways.
METhODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper. measured each time. All the neurons were included in each field. The mean value was taken as n = 1 for each mouse. If the staining was with fluorophoreconjugated secondary antibodies, the nuclear region of the same cells was used as background because the boundary of the nuclei was relatively clear. If the staining was for light microscopy with DAB, the adjacent neuropil region was used as background because the boundary of the nuclei was not as clear. The protein intensity value of the somatic region for each cell was equal to the value of the somatic region subtracting the background value. In Figure 6c , the non-somatic fluorescence density value was the direct measurements of the neuropil region. The cell counting for caspase 3−, calbindin D-28K− and TUNEL-positive cells as well as the NeuN-positive cells colabeled with cortical layers V or VI markers Er81 and Trb1 were quantified based on our previous study 47 . The mean positive staining was determined by counting 10-12 non-overlapping fields in specific layers in brain sections or in randomly chosen fields in cultures under 63× objective. The 10-12 non-overlapping fields were from three sections in each mouse or three dishes for each genotype in cultures for each experiment. The counts of three sections or three dishes were averaged and taken as n = 1. For the quantifications of the protein intensity in the somatic region in the immunohistochemistry, ImageJ was used.
digital histology and unbiased cell counting. For the brain sections with good representation of somatosensory cortex zone 1 and 2 (S1-2), we used the interaural 2.22 mm, Bregma 1.58 mm reference point based on the mouse brain atlas and cut 6-8 rostral sections at intervals of 5 µm from each mouse brain for the assay in cortex, hippocampus and thalamus. We prepared the cerebellar sections separately. The mouse brains were cut sagittally across the midline and 6-8 consecutive sections at intervals of 5 µm were prepared parasagittally starting from the midline in the right hemisphere. The images were acquired automatically by computer, and the image processing parameters were determined by the core personnel who were blind to mouse genotype. All the images were scanned at 20× and viewed with 7×. The total number of 5 × 10 5 µm 2 in somatosensory cortex were quantified manually by a person blind to genotype or by MetaMorph software. The cell counts of the 6-8 consecutive sections were averaged and taken as one of five pairs of mice.
Subcellular fractionation and isolation of synaptosomes. The procedures of subcellular fractionation were modified from a previous study 48 . Briefly, after quickly removing the brains, regions of interest were dissected and homogenized in pre-chilled homogenization HEPES-buffered sucrose buffer (HBS containing 0.32 M sucrose, 10 mM HEPES, pH 7.4, 2 mM EDTA) with a ratio of 10-ml buffer: 1 g of brain tissue (each mouse brain is around 0.4 g) with 10-15 strokes. The homogenates were then spun down at 1,000 g for 10 min to remove the cell debris and nuclei. The pellet was taken as P1. The supernatant was taken as S1, and S1 was centrifuged at 13,800 g for 20 min. The S1 pellet was taken as P2, and the supernatant was taken as S2. S2 was the combination of cytosol and light membranes, while P2 was crude synaptosomal fraction. P2 was resuspended with HBS buffer at 1:10 ratio and centrifuged at 13,800 g for 15 min (for wash). The washed pellet was then mixed with 9× vol ice cold H 2 O-protease inhibitors. After rapidly adjusting to 4 mM HEPES by using 1 M HEPES (pH 7.4), the P2 suspension was then rotated for 30 min at 4 °C, followed by spinning at 25,000g for 20 min. The pellet was taken as P3 and resuspended by adding 1.5 ml HBS buffer followed by discontinuous gradient sucrose ultracentrifuge. An equal volume (2.2 ml) of sucrose with different concentrations (1.4 M, 1.2 M, 1.0 M to 0.8 M) was added from bottom to top in the tube. The sample (1.5 ml) of P3 was added to the top of the sucrose layers. The sucrose tube containing the sample of P3 was then centrifuged at 150,000 g for 1 h, and then each layer of interest was carefully collected and stored at −80 °C. The synaptosome layer (spm) was at 1.0/1.2 M sucrose interface. live brain slice biotinylation. The protocol was based on a previous study 20 . Briefly, the brain slices were incubated for 45 min at 4 °C in artificial cerebrospinal fluid (aCSF) that contained 1 mg/ml of the membrane-impermeable, biotinylation reagent, sulfosuccinimidyl-2-(biotinamido)-ethyl-1,3′-dithiopropionate (Sulfo-NHS-SS-biotin; Thermo Scientific). After biotinylation, the slices were washed with 0.1 M glycine in aCSF. The cortices were dissected based on the region of interest and sonicated in radioimmunoprecipitation assay (RIPA) solution (20 mM Tris, pH 7.4, 1% Triton X-100, 250 mM NaCl) that also contained protease inhibitor mixture (1:100, Sigma-Aldrich), 0.5% deoxycholate (wt/vol) and 0.1% SDS (wt/vol).
Brain slice preparation and recording. Recordings of GABAergic mIPSCs were obtained from layer VI somatosensory cortex neurons in brain slices as previously described 20 . Coronal brain slice sections (300 µm) were made using a vibratome in ice-cooled solution containing (in mM) 214 sucrose, 2.5 KCl, 1.25 NaH 2 PO 4 , 0.5 CaCl 2 , 10 MgSO 4 , 24 NaHCO 3 , and 11 D-glucose, pH 7.4 bubbled with 95%O 2 /5%CO 2 at 4 °C. Slices were then incubated in oxygenated aCSF at 36 °C for 30 min. After this, slices were kept for at least 1 h before recording on a Nikon Eclipse FN-1 IR-DIC microscope at 22-26 °C. Pipette internal solution contained (in mM): 135 CsCl, 10 EGTA, 10 HEPES, 5 ATP-Mg, and QX-314 (5 mM) (pH 7.25, 290-295 mOsm), and recording micropipette resistances were 2-4 MΩ. Whole-cell patch clamp recordings were made at 22-26 °C from layer VI pyramidal neurons in SI/II somatosensory cortex visualized with an upright Nikon eclipse FN-1 IR-DIC microscope. Neurons in the layer above the white matter with a typical apical dendrite and large soma (smaller than the layer V neuronal somata) were chosen for recordings. Data were collected using a MultiClamp 700B amplifier with compensation for series resistance (70%) and cell capacitance. Data were filtered at 2 kHz and digitized at 20 kHz using a Digidata 1440A AD converter.
Synchronized eeg recordings and analysis. Synchronized video EEGs were recorded from 8-week-old to 4-month-old C57BL/6J mice 1 week after electrode implantation and recorded with synchronized EEG monitoring system from Pinnacle Technology based on previous study 49 . Briefly, mice were anesthetized with 1-3% isoflurane (vol/vol) and four epidural electrodes (stainless steel screws affixed to one head mount) were placed on the brain surface and secured in place with dental cement and surgical stiches. EMG leads were inserted into the trapezius muscle. Mice were allowed to recover from the EEG head mount implantation surgery for one week before EEG recording. Video-EEG monitoring lasted for 24-48 h, and mice were freely moving during EEG recordings. Mouse behaviors such as behavioral arrest, myoclonic jerks or generalized tonic-clonic seizures during the EEG recordings were identified to determine if mice exhibit behavioral seizures. At least 24 h of baseline EEG recordings were obtained and analyzed for each mouse.
open field test. Open field test was performed based on the standard protocol in Vanderbilt Neurobehavior core. Briefly, each individual mouse was placed into an open field activity chamber (Med Associates, 27 × 27 × 20.3 cm) that contained within light-and air-controlled environmental chambers for 60 min. Location and movement were detected by the interruption of infrared beams by the body of the mouse (16 photocells in each horizontal direction, as well as 16 photocells elevated 4 cm to measure rearing) and were measured by the Med Associates Activity Monitoring program. Total distance traveled and time resting in center (50% of area) and peripheral zone were measured. The open field arena was cleaned with 70% ethanol and wiped with paper towels between each trial. elevated zero maze test. The elevated zero maze is a modification of the elevated plus maze used for assessing anxiety-related behaviors. The elevated circular platform (40 cm off the ground, 50 cm in diameter) had two enclosed arenas opposite each other (5 cm wide with 15 cm high walls) and two open arenas (5 cm wide). Briefly, each mouse was lowered by its tail into the open arena of the maze and allowed to explore the maze for 300 s. The whole circular platform was cleaned with 70% ethanol and wiped with paper towels between each animal. Activity of the mouse was monitored via an overhead camera connected to a computer in a separate room using video acquisition and ANY-maze analysis software (Stoelting). Data analyzed included time spent in the open versus closed arms, the number of entry in the open arms.
Protein structure prediction and docking. We used MUFOLD 50 to predict the protein structures. The docking was performed by symmetric docking of SymmDock between two γ2 subunits and by general docking of PatchDock between the γ2 and α1 subunits 51 . Chimera (UCSF Chimera, a visualization system for exploratory research and analysis 52 ) was used to display the protein structures. 
